Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation

Radiotherapy and Oncology

Volumn 96, Issue 1, 2010, Pages 116-122

  Yaromina, Ala ^a   Thames, Howard ^b   Zhou, Xuanjing ^a   Hering, Sandra ^a   Eicheler, Wolfgang ^a   Dörfler, Annegret ^a   Leichtner, Thomas ^a   Zips, Daniel ^a   Baumann, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Fractionated radiotherapy; Human tumour xenograft; Local tumour control; Pimonidazole; Predictive assays; Radiobiological hypoxia; Tumour microenvironment; Tumour stem cells

Indexed keywords

PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CANCER CELL CULTURE; CANCER CONTROL; CANCER RADIOTHERAPY; FEMALE; HEAD AND NECK CARCINOMA; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IRRADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION; VASCULARIZATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL HYPOXIA; CONFIDENCE INTERVALS; DISEASE MODELS, ANIMAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NITROIMIDAZOLES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RADIOBIOLOGY; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT;

EID: 77953958780     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.04.020     Document Type: Article

References (52)

1. Overgaard J. Hypoxic radiosensitization: adored and ignored. J Clin Oncol 25 (2007) 4066-4074
2. Horsman M., Wouters B., Joiner M., and Overgaard J. The oxygen effect and fractionated radiotherapy. In: Joiner M., and Van der Kogel A. (Eds). Basic clinal radiobiology. 4th ed. (2009), Hodder Arnold, London 207-216
3. Baumann M., Krause M., and Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8 (2008) 545-554
4. Wouters B., and Koritzinsky M. The tumour microenvironment and cellular hypoxia responses. In: Joiner M., and Van der Kogel A. (Eds). Basic clincal radiobiology. 4th ed. (2009), Hodder Arnold, London 217-232
5. Moulder J.E., and Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10 (1984) 695-712
6. Baumann M., Appold S., Zimmer J., et al. Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy. Acta Oncol 40 (2001) 519-528
7. Evans S.M., Jenkins W.T., Joiner B., Lord E.M., and Koch C.J. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Res 56 (1996) 405-411
8. Raleigh J.A., Chou S.C., Arteel G.E., and Horsman M.R. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 151 (1999) 580-589
9. Kim I.H., Lemmon M.J., and Brown J.M. The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitroimidazole binding. Radiat Res 135 (1993) 411-417
10. Kavanagh M.C., Sun A., Hu Q., and Hill R.P. Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 histograph, [3H]misonidazole binding and paired survival assay. Radiat Res 145 (1996) 491-500
11. Kavanagh M.C., Tsang V., Chow S., et al. A comparison in individual murine tumors of techniques for measuring oxygen levels. Int J Radiat Oncol Biol Phys 44 (1999) 1137-1146
12. Sasai K., and Brown J.M. Discrepancies between measured changes of radiobiological hypoxic fraction and oxygen tension monitoring using two assay systems. Int J Radiat Oncol Biol Phys 30 (1994) 355-361
13. Petersen C., Eicheler W., Frommel A., et al. Proliferation and micromilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice. Int J Radiat Biol 79 (2003) 469-477
14. Lee J., Siemann D.W., Koch C.J., and Lord E.M. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. Int J Cancer 67 (1996) 372-378
15. Hirst D.G., Hazlehurst J.L., and Brown J.M. Changes in misonidazole binding with hypoxic fraction in mouse tumors. Int J Radiat Oncol Biol Phys 11 (1985) 1349-1355
16. Rofstad E.K., and Maseide K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int J Radiat Biol 75 (1999) 1377-1393
17. Hoogsteen I.J., Marres H.A., van der Kogel A.J., and Kaanders J.H. The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol (R Coll Radiol) 19 (2007) 385-396
18. Kaanders J.H., Bussink J., and van der Kogel A.J. Clinical studies of hypoxia modification in radiotherapy. Semin Radiat Oncol 14 (2004) 233-240
19. Yaromina A., Zips D., Thames H.D., et al. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) cell lines in nude mice. The need for a multivariate approach in biomarker studies. Radiother Oncol 81 (2006) 122-129
20. Yaromina A., Krause M., Thames H.D., et al. Pre-treatment number of clonogenic tumour cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol 83 (2007) 304-310
21. Starmans M.H., Zips D., Wouters B.G., Baumann M., and Lambin P. The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response. Radiother Oncol 92 (2009) 417-422
22. Yaromina A., Hölscher T., Eicheler W., et al. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?. Radiother Oncol 76 (2005) 206-212
23. Hessel F., Krause M., Helm A., et al. Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation. Int J Radiat Biol 80 (2004) 719-727
24. Walker A.M., and Suit H.D. Assessment of local tumor control using censored tumor response data. Int J Radiat Oncol Biol Phys 9 (1983) 383-386
25. Efron B., and Tibshirani R. Bootstrap measures for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1 (1986) 54-77
26. Bayer C., Schilling D., Hoetzel J., et al. PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck. Radiother Oncol 86 (2008) 361-368
27. Powers W.E., and Tolmach L.J. A multicomponent x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo. Nature 197 (1963) 710-711
28. Kim I.H., and Brown J.M. Reoxygenation and rehypoxiation in the SCCVII mouse tumor. Int J Radiat Oncol Biol Phys 29 (1994) 493-497
29. Gerweck L.E., Zaidi S.T., and Zietman A. Multivariate determinants of radiocurability. I: prediction of single fraction tumor control doses. Int J Radiat Oncol Biol Phys 29 (1994) 57-66
30. Zips D. Tumour growth and response to radiation. In: Joiner M., and van der Kogel A. (Eds). Basic clinical radiobiology. 4th ed. (2009), Hodder Arnold, London 78-101
31. Overgaard J., Eriksen J.G., Nordsmark M., Alsner J., and Horsman M.R. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol 6 (2005) 757-764
32. Rischin D., Hicks R.J., Fisher R., et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 24 (2006) 2098-2104
33. Suit H.D., and Maeda M. Hyperbaric oxygen and radiobiology of a C3H mouse mammary carcinoma. J Natl Cancer Inst 39 (1967) 639-652
34. Wouters B.G., and Brown J.M. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat Res 147 (1997) 541-550
35. Garcia-Barros M., Paris F., Cordon-Cardo C., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300 (2003) 1155-1159
36. Fuks Z., and Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 8 (2005) 89-91
37. Budach W., Budach V., Stuschke M., Dinges S., and Sack H. The TCD50 and regrowth delay assay in human tumor xenografts: differences and implications. Int J Radiat Oncol Biol Phys 25 (1993) 259-268
38. Brown M., Bristow R., Glazer P., et al. Comment on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (II). Science 302 (2003) 1894 (author reply)
39. Suit H.D., and Willers H. Comment on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (I). Science 302 (2003) 1894 (author reply)
40. Gerweck L.E., Vijayappa S., Kurimasa A., Ogawa K., and Chen D.J. Tumor cell radiosensitivity is a major determinant of tumor response to radiation. Cancer Res 66 (2006) 8352-8355
41. Baumann M., Dubois W., and Suit H.D. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Radiat Res 123 (1990) 325-330
42. Horsman M. Hypoxia in tumors: its relevance, identification, and modification. In: Beck-Bornholdt H.P. (Ed). Current topics in clinical radiobiology of tumors (1993), Springer, Berlin 99-112
43. Kavanagh M.C., Minkin S., and Hill R.P. The use of needle biopsies for radiobiological assessment of oxygen levels in KHT-C tumors. Radiat Res 152 (1999) 107-112
44. Gulliksrud K., Vestvik I.K., Galappathi K., Mathiesen B., and Rofstad E.K. Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry. Radiat Res 170 (2008) 638-650
45. Vaupel P., and Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26 (2007) 225-239
46. Aebersold D.M., Beer K.T., Laissue J., et al. Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys 48 (2000) 17-25
47. Jenssen N., Boysen M., Kjaerheim A., and Bryne M. Low vascular density indicates poor response to radiotherapy in small glottic carcinomas. Pathol Res Pract 192 (1996) 1090-1094
48. Koukourakis M.I., Giatromanolaki A., Sivridis E., and Fezoulidis I. Cancer vascularization: implications in radiotherapy?. Int J Radiat Oncol Biol Phys 48 (2000) 545-553
49. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
50. Wouters B.G., and Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8 (2008) 851-864
51. Dewhirst M.W., Cao Y., and Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8 (2008) 425-437
52. Bristow R.G., and Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8 (2008) 180-192